RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Fact checked by Jennifer Klump Although respiratory syncytial virus (RSV) is often associated with children, adults can also ...

Bay Area doctors detail which vaccines adults 50 and older should get now - pneumococcal, RSV, flu, shingles, COVID - and why ...

Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, highlighting the need for targeted outreach programs.

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

RSV vaccines are on the way: Here's what the CDC says about them. In the fall, Pfizer said results from a Phase 3 clinical trial showed its vaccine protected infants when given to pregnant ...

The FDA will decide whether or not to approve an RSV vaccine by August 2023. After decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory ...

A vaccine to protect against severe cases of Respiratory Syncytial Virus could roll out as early as August. Pfizer has developed RSVpreF, a vaccine to prevent severe cases of RSV, and the Food and ...

Moderna's respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday. Adult ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age ...

Another future RSV vaccine would target pregnancy. Vaccinating pregnant people would also produce antibodies in their unborn fetuses, allowing them to bring their babies into the world with ...